5 High Growth Stocks to Buy Right Now

In this article, we will list the 5 High Growth Stocks to Buy Right Now. Please visit 10 High Growth Stocks to Buy Right Now to see the extended list and the methodology behind it.

5. Neurocrine Biosciences Inc. (NASDAQ:NBIX)

Number of Hedge Fund Holders: 53

Neurocrine Biosciences Inc. (NASDAQ:NBIX) is one of the high growth stocks to buy right now. On June 15, Neurocrine Biosciences presented findings from the first retrospective case series evaluating CRENESSITY (crinecerfont) in patients with classic congenital adrenal hyperplasia/CAH due to 11β-hydroxylase deficiency (11β-OHD). This study provides preliminary evidence for a rare CAH subtype previously unexamined in clinical trials, showing that the treatment significantly reduces adrenal hormone and steroid precursor levels.

In the study of 15 pediatric and adult patients, the initiation of CRENESSITY led to median reductions of over 90% in 11-deoxycortisol and 11-deoxycorticosterone. Furthermore, 14 out of 15 patients were able to decrease their total daily glucocorticoid dose, and some patients receiving antihypertensive medication were able to reduce or discontinue their use of those drugs, reflecting improved hormonal and clinical control.

These findings offer foundational clinical insights into the potential for CRENESSITY to manage the complex hormonal imbalances associated with 11β-OHD. By targeting ACTH, the treatment appears to help normalize hormone levels that contribute to hypertension and other complications, supporting the company’s commitment to advancing care for all patients across the spectrum of classic CAH.

Neurocrine Biosciences Inc. (NASDAQ:NBIX) is a biopharmaceutical company with a focus on neuroscience. It is involved in the R&D, sale, and commercialization of pharmaceuticals that treat neuroendocrine, neurological, and neuropsychiatric disorders.